Breaking News
Get 40% Off 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

Phaxiam Therapeutics SA DRC (PHXM)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Phaxiam Therapeutics DRC's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Phaxiam Therapeutics DRC historical data, for real-time data please try another search
3.100 0.000    0.00%
08/03 - Closed. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 0
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 3.050 - 3.100
Phaxiam Therapeutics DRC 3.100 0.000 0.00%

Phaxiam Therapeutics SA DRC Company Profile

 
Get an in-depth profile of Phaxiam Therapeutics SA DRC, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

45

Equity Type

ADR

PHAXIAM Therapeutics S.A., a biopharmaceutical company, focuses on developing treatments for resistant bacterial infections in France and the United States. It develops eryaspase, which is in Phase 3 clinical development for the treatment of second-line pancreatic cancer, and in Phase 2 stage for the treatment of triple-negative breast cancer and second-line acute lymphoblastic leukemia patients. The company also engages in developing a portfolio of phages targeting resistant and dangerous bacteria, which together account for more than two-thirds of resistant hospital-acquired infections, including staphylococcus aureus, escherichia coli, and pseudomonas aeruginosa. The company was formerly known as ERYTECH Pharma S.A. and changed its name to PHAXIAM Therapeutics S.A. in June 2023. PHAXIAM Therapeutics S.A. was incorporated in 2004 and is headquartered in Lyon, France.

Contact Information

Address 60 Avenue Rockefeller Bâtiment Adénine
Lyon, 69008
France
Phone 33 4 78 74 44 38
Fax 33 4 78 75 56 29
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

PHXM Comments

Write your thoughts about Phaxiam Therapeutics SA DRC
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
IMRAN HOSSAIN
IMRAN HOSSAIN Jul 31, 2021 8:44PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
nice
Victor Martin
Victor Martin Jul 30, 2021 2:18PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
volumes are crazy, something is happening on this stock...
Mihai Muntean
Mihai Muntean Jul 30, 2021 2:00PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
how buy something on this app
Ab High
Ab High Jul 30, 2021 1:01PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Out
Victor Martin
Victor Martin Jul 30, 2021 11:45AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
A possible takeover ? Target Price 30 $, it would be crazy
Ab High
Ab High Jul 30, 2021 8:46AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Out jump
Jul 30, 2021 8:01AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Im out now
Salman Ghaith
Salman Ghaith Jul 29, 2021 7:04PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
So ... In or Out?
Dragan Soldat
Dragan Soldat Jul 29, 2021 7:04PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Richard Fortin
Richard Fortin Jul 29, 2021 7:04PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
to late to get in
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email